1
Views
1
CrossRef citations to date
0
Altmetric
Original Article

An Investigation of the Protein Components of Amyloid Using Immunoperoxidase and Permanganate Methods on Tissue Sections

Pages 137-140 | Accepted 11 Jun 1985, Published online: 06 Jul 2009

References

  • Glenner GG. Amyloid deposits and amyloidosis: The betafibrilloses (two parts). N Engl J Med 1980; 302: 1283–92; 1333–43
  • Cohen A S, Shirahama T, Sipe J D, Skinner M. Amyloid proteins, precursors, mediator and enhancer. Lab Invest 1983; 48: 1–4
  • Cathcart E S, Ritchie R F, Cohen A S, Brandt K. Immunoglobulins and amyloidosis: An immunological study of sixty-two patients with biopsy-proved disease. Am J Med 1972; 52: 93–101
  • Watanabe S, Jaffe E, Pollock S, et al. Amyloid AA protein: cellular distribution and appearance. Am J Clin Pathol 1977; 67: 540–4
  • Glenner G G, Page DL. Amyloid, amyloidosis and amyloidogenesis. Int Rev Exp Pathol 1976; 15: 1–92
  • Black M M, Wilson Jones E. Macular amyloidosis: A study of 21 cases with special reference to the role of the epidermis in its histogenesis. Br J Dermatol 1971; 84: 199–209
  • Prathap K, Looi L M, Prasad U. Localised amyloidosis in nasopharyngeal carcinoma. Histopathology 1984; 8: 27–34
  • Looi LM. Localised amyloidosis in basal cell carcinoma: a pathologic study. Cancer 1983; 52: 1833–6
  • Westermark P, Gibbons G, Cornwell I, II, . Senile cardiac amyloidosis. Amyloid and Amyloidosis, G G Glenner, P P Costa, A F Freitas, et al. Excerpta Medica, Amsterdam 1980; 212–25
  • Goffin Y. Microscopic amyloid deposits in the heart valves: a common local complication of chronic damage and scarring. J Clin Pathol 1980; 33: 262–8
  • Looi LM. Microscopic atrial amyloidosis in chronic heart disease. Histopathology 1981; 5: 615–22
  • Shirahama T, Skinner M, Westermark P, et al. Senile cerebral amyloid: prealbumin as a common constituent in the neuritic plaque, in the neurofibrillary tangle, and in the microangiopathic lesion. Am J Pathol 1982; 107: 41–50
  • Westermark P, Shirahama T, Skinner M, et al. lmmunohistochemical evidence for the lack of amyloid P component in some intracerebral amyloids. Lab Invest 1982; 46: 457–60
  • Renu S J, Valenzuela R, Guerrero I, et al. lmmunofluorescence findings in human renal amyloidosis. Am J CIin Pathol 1980; 74: 630–5
  • Noren P, Westermark P, Cornwell I GG, II, Murdoch W. Immunofluorescence and histochemical studies of localized cutaneous amyloidosis. Br J Dermatol 1983; 108: 277–85
  • MacDonald D M, Fergin P E, Black MM. Localised cutaneous amyloidosis. Amyloid and Amyloidosis, G G Glenner, P P Costa, A F Freitas. Excerpta Medica, Amsterdam 1980; 239–42
  • Wright J R, Calkins E, Humphrey RL. Potassium permanganate reaction in amyloidosis: A histologic method to assist in differentiating forms of this disease. Lab Invest 1977; 36: 274–81
  • Benditt E P, Cohen A S, Costa PP, . Guidelines for nomenclature. Amyloid and Amyloidosis, G G Glenner, P P Costa, A F Freitas, et al. Excerpta Medica, Amsterdam 1980; XI–XII
  • Looi L M, Prathap K. Amyloidosis in the Malaysian Aborigines (Orang Ash). Pathology 1979; 11: 575–82
  • Cathcart E S, Skinner M, Cohen AS. lmmunogenicity of arnyloid. Immunology 1971; 20: 945–54
  • Cornwell I GG, II, Husby G, Westermark P, et al. ldentification and characterization of different amyloid fibril proteins in tissue sections. Scand J Immunol 1977; 6: 1071–80
  • Ravid M, Robson M, Kedar I. Prolonged colchicine treatment in four patients with amyloidosis. Ann Intern Med 1977; 87: 568–70
  • van Rijswijk M H, Donker A J, Ruinen L. Dimethylsulphoxide in amyloidosis. Lancet 1979; 1: 207–8
  • Kisilevsky R, Boudreau L, Foster D. Kinetics of amyloid deposition. The effects of dimethysulfoxide and colchicine therapy. Lab Invest 1983; 48: 60–7
  • Corkery J, Bern M M, Tullis JL. Resolution of amyloidosis and plasma-cell dyscrasia with combination chemotherapy. Lancet 1978; 2: 425–6
  • Bedi T R, Datta BN. Diffuse biphasic cutaneous amyloidosis. Dermatologica 1979; 158: 433–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.